Aphrodite Health, a new biotech company in the rapidly emerging multibillion dollar psychedelic medicine sector, launches today. Founded by women, and focused on addressing women’s mental and physical health with psychedelic enhanced treatments, the company has developed a two pronged approach, with a long term drug discovery program to bring an FDA approved drug to market. Aphrodite Health is a US-based psychedelic…
Is student engagement in the femtech community crucial in raising awareness of the field among researchers, innovators and future entrepreneurs? Lesley Farrah Dorwling-Carter and Emily Otterbeck, two students currently enrolled in Cambridge University’s MPhil in Bioscience Enterprise Program, certainly think so! And this belief has recently led them to launching the Cambridge Femtech Society, the first official society dedicated to women’s health…
Rae, a socially-conscious, women-led wellness brand dedicated to supporting the well-being of all, today announced the close of a $9.5 million Series A investment round led by PowerPlant Partners. PowerPlant Partners is joined by M13 and Able Partners, two existing Rae investors, and supported by initial capital investor Victress Capital. The financing provides Rae with the capital runway it needs to accelerate growth to…
Women’s health startup Tia today announced the opening of its third location in Phoenix. Just months ago the company opened its second location in Los Angeles and announced a partnership with Common Spirit. Tia is known for championing the concept of “Whole Person Health” and aims to recreate a healthcare system that was designed for specialties, body parts, and treating sickness. The company announced…
Merck spin-off Organon today celebrates its launch as a global women’s health company with employees and women from around the world, as the Organon executive leadership team rings the opening bell at the New York Stock Exchange (NYSE). Recognizing the need to listen to and act on women’s experiences to address the challenges in women’s health, Organon gathered voices from around the…
Biotech company SCYNEXIS has announced FDA (U.S. Food and Drug Administration) approval of BREXAFEMME (ibrexafungerp tablets) for oral use in patients with vulvovaginal candidiasis (VVC), also known as vaginal yeast infection. BREXAFEMME is the first approved drug in a novel antifungal class in more than 20 years and was approved based on positive results from two Phase 3 studies in which oral ibrexafungerp demonstrated…
Femtech startup Emme today announced the launch of EmmeRx, a birth control pill prescription delivery and telemedicine service. EmmeRx builds upon the success of the Emme Smart Case, which has been shown to deliver an 80% reduction in missed birth control pills. The new service is currently available in 16 states. Emme was co-founded in 2017 by Amanda French and Janene Fuerch,…
To help remove the stigma around fertility CCRM Fertility has launched The F-Word Collection, an ecommerce shop that features a diverse collection of hand-picked products from women-owned businesses passionate about fertility. The shop is part of a larger campaign by CCRM Fertility to normalize the conversations about fertility and give people an easy way to show their support. Proceeds from the shop…
